中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Metabolic study of ginsenoside Re in rats

文献类型:期刊论文

作者CHEN Guangtong2; YANG Min1; GUO Dean1
刊名China Journal of Chinese Materia Medica
出版日期2009
卷号34期号:12页码:1540-1543
关键词LC-MS/MS ginsenoside Re metabolism LC-MS/MS
ISSN号1001-5302
其他题名人参皂苷Re在大鼠体内的代谢研究
文献子类Article
英文摘要Objective:To systemically study the metabolism of ginsenoside Re in rats. Method: Six SD rats were used divided into 3 groups. After oral administration of ginsenoside Re at a dosage of 100 mg ·kg~(-1),feces were collected at 12, 24, 36, 48, and 60 h. The microbial transformation metabolites of ginsenoside Re were used as standard references. HPLC-ESI-MS/MS analysis was used in the metabolism studies. Result: Six metabolites of ginsenoside Re were detected in rat feces by HPLC-ESI-MS/MS analysis. Their structures were identified as 20(S)-ginsenoside Rg_2,20(S)-ginsenoside Rh_1,20(R)-ginsenoside Rh_1,ginsenoside F_1,3-oxo-ginsenoside Rh_1, and protopanaxatriol. Conclusion: Ginsenoside Re has the same metabolic pathway with microorganisms, to some extent, justified the use of microbial models for mammalian metabolism studies.
WOS研究方向General & Internal Medicine (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:3759233
源URL[http://119.78.100.183/handle/2S10ELR8/267974]  
专题上海中药现代化研究中心
作者单位1.Shanghai Research Center for Modernization of Traditional Chinese Medicine, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
2.Medical College, Nantong University, Nantong, Jiangsu 226001, China.;
推荐引用方式
GB/T 7714
CHEN Guangtong,YANG Min,GUO Dean. Metabolic study of ginsenoside Re in rats[J]. China Journal of Chinese Materia Medica,2009,34(12):1540-1543.
APA CHEN Guangtong,YANG Min,&GUO Dean.(2009).Metabolic study of ginsenoside Re in rats.China Journal of Chinese Materia Medica,34(12),1540-1543.
MLA CHEN Guangtong,et al."Metabolic study of ginsenoside Re in rats".China Journal of Chinese Materia Medica 34.12(2009):1540-1543.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。